AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 223 filers reported holding AXSOME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,540,726 | -2.7% | 93,586 | 0.0% | 1.75% | +29.0% |
| Q2 2023 | $6,725,090 | +54.9% | 93,586 | +32.9% | 1.35% | +20.0% |
| Q1 2023 | $4,342,395 | +8.3% | 70,402 | +35.5% | 1.13% | +8.5% |
| Q4 2022 | $4,008,832 | -3.0% | 51,975 | -47.9% | 1.04% | -6.2% |
| Q1 2022 | $4,132,000 | +5.8% | 99,834 | -3.5% | 1.11% | +55.8% |
| Q4 2021 | $3,907,000 | +7.6% | 103,405 | -6.1% | 0.71% | +26.5% |
| Q3 2021 | $3,631,000 | – | 110,155 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |